Your browser doesn't support javascript.
loading
Safety, immunogenicity, and efficacy of NDV-3A against Staphylococcus aureus colonization: A phase 2 vaccine trial among US Army Infantry trainees.
Millar, Eugene V; Bennett, Jason W; Barin, Burc; Carey, Patrick M; Law, Natasha N; English, Caroline E; Schwartz, Michael M; Cochrane, Terrence; Ellis, Michael W; Tribble, David R; Timothy Cooke, M; Hennessey, John P.
Afiliación
  • Millar EV; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, United States; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States. Electronic ad
  • Bennett JW; Walter Reed Army Institute of Research, Silver Spring, MD, United States.
  • Barin B; The Emmes Company, Rockville, MD, United States.
  • Carey PM; Benning Martin Army Community Hospital, Fort Benning, GA, United States.
  • Law NN; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, United States; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States; Benning Marti
  • English CE; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, United States; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States.
  • Schwartz MM; NovaDigm Therapeutics, Inc., Grand Forks, ND, United States.
  • Cochrane T; NovaDigm Therapeutics, Inc., Grand Forks, ND, United States.
  • Ellis MW; University of Toledo Medical Center, Toledo, OH, United States.
  • Tribble DR; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.
  • Timothy Cooke M; NovaDigm Therapeutics, Inc., Grand Forks, ND, United States.
  • Hennessey JP; NovaDigm Therapeutics, Inc., Grand Forks, ND, United States.
Vaccine ; 39(23): 3179-3188, 2021 05 27.
Article en En | MEDLINE | ID: mdl-33962841
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones Estafilocócicas / Vacunas Estafilocócicas / Vacunas / Personal Militar Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Vaccine Año: 2021 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones Estafilocócicas / Vacunas Estafilocócicas / Vacunas / Personal Militar Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Vaccine Año: 2021 Tipo del documento: Article Pais de publicación: Países Bajos